Sandbox/AL: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Antithrombin III}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{JH}} | ||
'''''For patient information, click <u>[[ | '''''For patient information, click <u>[[Antithrombin III (patient information)|here]]'''''</u>. | ||
==Overview== | ==Overview== | ||
==Category== | |||
==US Brand Names== | |||
'''THROMBATE III'''<sup>®</sup> | |||
==FDA Package Insert== | |||
'''| [[Antithrombin III indications and usage|Indications and Usage]]''' | |||
'''| [[Antithrombin III dosage and administration|Dosage and Administration]]''' | |||
'''| [[Antithrombin III dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[Antithrombin III contraindications|Contraindications]]''' | |||
''' [[ | '''| [[Antithrombin III warnings|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Antithrombin III adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Antithrombin III drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[Antithrombin III use in specific populations|Use in Specific Populations]]''' | ||
'''| [[ | '''| [[Antithrombin III overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Antithrombin III description|Description]]''' | ||
'''| [[ | '''| [[Antithrombin III clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Antithrombin III nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[ | '''| [[Antithrombin III clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[Antithrombin III how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[ | '''| [[Antithrombin III patient counseling information|Patient Counseling Information]]''' | ||
'''| [[ | '''| [[Antithrombin III labels and packages|Labels and Packages]]''' | ||
'''| [[ | |||
'''| [[ | |||
'''| [[ | |||
'''| [[ | |||
==Mechanism of Action== | ==Mechanism of Action== | ||
==References== | ==References== | ||
{{Cite web | last = | first = | title = THROMBATE III (ANTITHROMBIN III) KIT [GRIFOLS USA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2a9f856-3ef7-8da4-920c-f738e4f1f7d7 | publisher = | date = | accessdate = 7 March 2014 }} | |||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 14:37, 8 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]
For patient information, click here.
Overview
Category
US Brand Names
THROMBATE III®
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
References
"THROMBATE III (ANTITHROMBIN III) KIT [GRIFOLS USA, LLC]". Retrieved 7 March 2014.